Morgan Stanley analyst Michael Ulz reiterated a Buy rating on Sarepta Therapeutics (SRPT – Research Report) today and set a price target ...

Analyst Gena Wang of Barclays maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report), retaining the price target of ...

Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report)‘s stock had its “outperform” rating restated by Raymond James in a ...

On Thursday, Sarepta Therapeutics Inc (SRPT) stock saw a modest uptick, ending the day at $122.41 which represents a slight increase of $4.42 or 3.75% from the prior close of $117.99. The stock opened ...

Capricor Therapeutics (NASDAQ:CAPR) stock rose 5% in midday trading Friday after the company reported positive long-term data ...

SunOpta (NASDAQ:STKL – Get Free Report) (TSE:SOY) was upgraded by stock analysts at StockNews.com from a “sell” rating to a “hold” rating in a research note issued to investors on Thursday. SunOpta ...

Six years ago, Sanofi gave $125 million and promised over $1 billion in milestone payments to buzzy neuroscience startup ...

Investing.com - Edgewise Therapeutics (NASDAQ: EWTX) reported fourth quarter EPS of $-0.34, in line with the analyst estimate of $-0.34. Revenue for the quarter came ...

In the last weeks of the presidential campaign, the world’s richest man has involved himself in the U.S. election in a manner unparalleled in modern history. 7 min read A Misleading Question ...

While Milton did not trigger the catastrophic surge of seawater feared in Florida, the clean-up operation could take many weeks or months. United Statescategory Trump expected to play up fears of ...

A Woman Won South Korea’s First Literature Nobel. That Says a Lot. While Han Kang’s victory was celebrated as a crowning cultural achievement for her country, her work also represents a form ...